Epirubicin Hydrochloride Injection 10 & 50 mg

Epirubicin will be given  by a doctor or nurse, either into a vein or directly into patient's bladder

Correct dose and number of days treatment  will depend on the type of cancer , health, height, weight of patient.

When injected into the bloodstream, Epirubicin is used to treat cancers of the breast, stomach and lung as well as advanced ovarian cancer.

When injected into the bladder through a tube, Epirubicin is used to treat cancers of the bladder wall. It can also be used after other treatments for prevention of such cells from growing again.

Very common (occur in more than 1 in 10 people):

Hair loss, reduced growth of beard hair.

Common (occur in less than 1 in 10 people):

Allergic reactions, feeling or being sick, diarrhoea (which can result in dehydration), loss of appetite, abdominal pain, inflammation of the gullet (oesophagitis), high levels of pigments in the mouth, swelling and pain in your mouth, ulcers involving the lips and/or tongue and/or under the tongue, hot flushes, changes in blood cells causing bleeding, fever or infections.

Uncommon (occur in less than 1 in 100 people):

Headache, high levels of pigments in the skin and nails, skin redness, sensitivity to light (in case of radiotherapy), vein inflammation including blood clotting (thrombophlebitis).

Rare (occur in less than 1 in every 1,000 people):

Hives (urticaria), fever and/or chills, dizziness, absence of menstrual periods (amenorrhea), lack of sperm, gout, changes in heart or liver function.

Longterm effect is a certain type of leukaemia (acute myeloid leukaemia) which has been rarely reported.

If epirubicin hydrochloride is injected directly into the bladder patient may experience pain or difficulty when passing urine. Blood may also be seen in urine.